Evidence map›Paper›PMID 42044120›Full record

ArticlePLoS pathogens2026

Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis.

Fergal J Duffy, Maxwell L Neal, Courtney R Plumlee, Sara B Cohen, Benjamin H Gern, Alan H Diercks, Michael Y Gerner, Kevin B Urdahl, John D Aitchison

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fergal J DuffyCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0002-4675-0937
Maxwell L NealCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Courtney R PlumleeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Sara B CohenCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Benjamin H GernCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Alan H DiercksCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Michael Y GernerUniversity of Washington, Department of Immunology, Seattle, Washington, United States of America.
Kevin B UrdahlCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0001-6362-8821
John D AitchisonCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0002-9153-6497

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
NIH HHS 75N93019C00070
6 · The paper itself

Abstract

The mechanisms that underlie protective immunity to Mycobacterium tuberculosis (Mtb) remain incompletely defined. To identify immune correlates associated with protection, we performed single-cell RNA sequencing of lung immune cells after aerosol Mtb infection of naïve mice and mice with contained Mtb infection (CoMtb), a model of naturally acquired resistance, across multiple time points, mouse strains, and Mtb strains. Protection was associated with distinct temporal patterns of immune activation, cell recruitment, and resolution. Early after challenge, CoMtb mice exhibited rapid, transient recruitment and activation of CD4 ⁺ T cells, macrophages, NK, and NKT cells, accompanied by short-lived bursts of type I and II interferon signaling, increased oxidative phosphorylation, and enhanced chemokine-mediated cell-cell communication. In contrast, primary infection elicited delayed but sustained interferon and neutrophil responses and higher bacterial burdens. These data indicate that protection involves dynamically coordinated immune pathways rather than the magnitude of any single response. Transcriptional features of CoMtb overlapped with those observed in nonhuman primates following intravenous BCG vaccination, including enrichment of activated tissue-resident CD4 ⁺ T cells and innate effector populations. Together, these findings support a model in which effective immunity to Mtb depends on the timing and coordination of immune activation, providing a framework for vaccine strategies that reproduce protective lung immune dynamics.

Indexed as

LungMycobacterium tuberculosisTuberculosisTuberculosis, PulmonaryAnimalsCD4-Positive T-LymphocytesDisease SusceptibilityFemaleImmunity, InnateMacrophagesMiceMice, Inbred C57BLSingle-Cell Analysis

Identifiers

PMID42044120
PMCPMC13119832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.